NASDAQ:BHST BioHarvest Sciences (BHST) Stock Price, News & Analysis $6.27 -0.08 (-1.26%) As of 05/30/2025 03:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About BioHarvest Sciences Stock (NASDAQ:BHST) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BioHarvest Sciences alerts:Sign Up Key Stats Today's Range$6.25▼$6.3550-Day Range$5.25▼$6.7552-Week Range$6.25▼$7.38Volume8,890 shsAverage Volume17,070 shsMarket Capitalization$102.98 millionP/E RatioN/ADividend YieldN/APrice Target$13.67Consensus RatingBuy Company OverviewBioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.Read More… Receive BHST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioHarvest Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address BHST Stock News HeadlinesBioHarvest enters fragrance industry with AI edge - ICYMIMay 23, 2025 | proactiveinvestors.comDiamond Equity Research Releases Update Note on BioHarvest Sciences Inc. (NASDAQ: BHST)May 23, 2025 | finance.yahoo.comBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.June 2, 2025 | Stansberry Research (Ad)HC Wainwright Has Pessimistic Outlook of BHST Q2 EarningsMay 23, 2025 | americanbankingnews.comBioHarvest inks fragrance compound deal in move into multi-billion-dollar scents marketMay 21, 2025 | proactiveinvestors.comBioHarvest Sciences advances CDMO deal with major pharmaceutical company - ICYMIMay 17, 2025 | proactiveinvestors.comBioHarvest Sciences Inc. (BHST) Q1 2025 Earnings Call TranscriptMay 16, 2025 | seekingalpha.comBioHarvest Sciences Q1 revenue jumps on VINIA growthMay 15, 2025 | proactiveinvestors.comSee More Headlines BHST Stock Analysis - Frequently Asked Questions How have BHST shares performed this year? BioHarvest Sciences' stock was trading at $6.18 at the beginning of the year. Since then, BHST stock has increased by 1.5% and is now trading at $6.27. View the best growth stocks for 2025 here. How were BioHarvest Sciences' earnings last quarter? BioHarvest Sciences Inc. (NASDAQ:BHST) issued its quarterly earnings data on Thursday, May, 15th. The company reported ($0.13) earnings per share for the quarter, topping analysts' consensus estimates of ($0.15) by $0.02. The firm had revenue of $7.64 million for the quarter, compared to analyst estimates of $8.93 million. Read the conference call transcript. Who are BioHarvest Sciences' major shareholders? Top institutional investors of BioHarvest Sciences include Magnus Financial Group LLC (0.44%) and True North Advisors LLC (0.27%). How do I buy shares of BioHarvest Sciences? Shares of BHST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/15/2025Today6/01/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:BHST Previous SymbolNASDAQ:BHST CIK1723464 Webbioharvest.com Phone646-863-2177FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Target$13.67 High Stock Price Target$15.00 Low Stock Price Target$12.00 Potential Upside/Downside+118.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.50) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$12.56 million Net Margins-76.65% Pretax Margin-76.65% Return on EquityN/A Return on Assets-85.16% Debt Debt-to-Equity RatioN/A Current Ratio0.80 Quick Ratio0.48 Sales & Book Value Annual Sales$27.70 million Price / Sales3.72 Cash FlowN/A Price / Cash FlowN/A Book Value($1.08) per share Price / Book-5.81Miscellaneous Outstanding Shares16,425,000Free FloatN/AMarket Cap$102.98 million OptionableN/A Beta0.80 20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free Report This page (NASDAQ:BHST) was last updated on 6/2/2025 by MarketBeat.com Staff From Our PartnersThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored“You all just got a lot richer”Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crash...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioHarvest Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioHarvest Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.